Funders · Entity Annotation Prototype (beta)

2articles mentioning funders

2funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: EU Clinical Trials Information System ×

EU Clinical Trials Information System

This funder is selected. Its supporting articles are shown below.

EU Clinical Trials Information System2

Articles mentioning EU Clinical Trials Information System

2 articles · page 1 of 1

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations

bmjresp · abstract · 2026-07-20 · 1 matching annotations

88.3%

EU Clinical Trials Information System tozorakimab chronic obstructive pulmonary disease TITANIA COPD OBERON MIRANDA

… review boards. Results of the studies will be submitted to the EU Clinical Trials Information System within a year from the global end of trial data in all particip…

Intranasal sufentanil versus ketamine for acute severe traumatic pain in children: protocol for a phase II randomised controlled trial (SUF-KET-PED)

bmjopen · abstract · 2026-05-20 · 1 matching annotations

82.6%

EU Clinical Trials Information System IDRCB ketamine Visual Analogue Scale sufentanil Lenval Children’s Hospital French Ethics Committee CPP Sud Méditerranée V